Moscow, Russia

Oleg Leonidovich Kalia

This inventor holds 2 USPTO granted patents. Top assignees: Federalnoe Gosudarstvennoe Unitarnoe Predpriyatie “Gosudarstvenny Nauchny Tsentr Nauchno-Issledovatelsky Institut Organicheskikh Poluproduktov I Krasitelei” (Fgup “Gntts Niopik”), Gosudarstevennoe Obrazovatelnoe Uchrezhdenie Vysshego Professionalnogo Obrazovaniya Moskovskaya Meditsinskaya Akademiya Im. I.m. Sechenova Rf (Gouvpo Mma Im. I.m. Sechenova Mz Rf), Gosudarsvenny Nauchy Tsentr Rossiiskoi Federatsii 'Niopik'. Active years: 1999-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Oleg Leonidovich Kalia. Retrieved from https://idiyas.com/inventor/oleg-leonidovich-kalia

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1999-2007

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations in Liver Cancer Treatment: The Contributions of Oleg Leonidovich Kalia

Introduction

Oleg Leonidovich Kalia, based in Moscow, Russia, is an influential inventor known for his significant contributions to the field of medical treatments, particularly in oncology. With a focus on innovative therapies for liver tumors, Kalia holds two patents that demonstrate his commitment to improving patient outcomes.

Latest Patents

Kalia's latest patents include a groundbreaking method for the therapy of liver tumors. This method involves the regional administration of preparations during liver tumor therapy. Specifically, it entails administering a preparation into a branch of the portal vein while simultaneously occluding the relevant afferent and efferent vessel branches for a duration of 5 to 15 minutes. The method emphasizes the predominant accumulation of preparations in the tumor carrier lobe of the liver, significantly reducing systemic blood flow penetration and thereby minimizing toxicity and dosage requirements. Additionally, Kalia has developed an agent for suppressing tumor growth, which adds to his repertoire of innovative medical solutions.

Career Highlights

Throughout his career, Oleg Leonidovich Kalia has been affiliated with prominent research institutions. He has worked with the Institute of Elemento-organic Compounds of the Russian Academy of Sciences and the State Scientific Center of the Russian Federation 'NIIOP'. His experiences in these significant organizations have shaped his research and inventions.

Collaborations

Kalia's work has been further enriched through collaborations with notable colleagues, including Georgy Nikolaevich Vorozhtsov and Natalya Ivanovna Kazachkina. These partnerships have helped in refining his methods and advancing innovative solutions in the treatment of liver tumors.

Conclusion

Oleg Leonidovich Kalia stands out as a prominent inventor in the field of medical innovation. His patents not only demonstrate a profound understanding of cancer therapy but also reflect his dedication to enhancing treatment methods for liver tumors. Through his continued research and collaboration with esteemed professionals, Kalia is making significant strides in the fight against cancer, paving the way for more effective therapeutic strategies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…